EP1588704A1 — Alpha-aminoamide derivatives useful in the treatment of restless legs syndrome and addictive disorders
Assigned to Newron Pharmaceuticals SpA · Expires 2005-10-26 · 21y expired
What this patent protects
Methods of using certain α-aminoamide derivatives in the treatment of RLS and addictive disorders. The compounds of this invention are able to reduce or even stop the syntoms of RLS and addictive disorders substantially without side effects.
USPTO Abstract
Methods of using certain α-aminoamide derivatives in the treatment of RLS and addictive disorders. The compounds of this invention are able to reduce or even stop the syntoms of RLS and addictive disorders substantially without side effects.
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.